AMP Health logo

AMP Health Review

Site is down for maintenance and not taking orders
6.6
★★★☆☆3.3/5

AMP Health scores below our bar on medical oversight — read the score breakdown before signing up.

Semaglutide

$199/mo

Tirzepatide

$309/mo

AMP Health: Site is down for maintenance and not taking orders. We're not linking to it. Here are the top-rated GLP-1 providers we recommend instead.

See our top-rated GLP-1 providers →
Compare top-rated alternatives ↓

AMP Health offers compounded semaglutide (injectable and oral) from $199/mo and tirzepatide from $309/mo, plus a $79/mo subscription fee. Brand Wegovy listed but out of stock. 30-day satisfaction guarantee.

By Eli Marsden · Founding Editor
Editorially reviewed & fact-checked against primary sources · How we verify contentLast reviewed
CompoundedOral OptionSemaglutideTirzepatide

WeightLossRankings.org is reader-supported. When you buy through links on our site, we may earn an affiliate commission. Learn more

Vetted alternatives to AMP Health

8.0/ 10
Verified partner

Sesame Care

Best for: Brand-name GLP-1s at cash prices, no compounding

★★★★4/5

Editorial score · methodology

$149/mosemaglutide
$299/motirzepatide
CompoundedSemaglutideTirzepatideOrforglipron
Get StartedRead full Sesame Care review →
8.3/ 10
Verified partner

Collective

Best for: the lowest flat medication price if you can absorb an annual membership fee

★★★★4.2/5

Editorial score · methodology

$59/mosemaglutide
$69/motirzepatide
CompoundedSemaglutideTirzepatide
Get StartedRead full Collective review →
6.9/ 10
Verified partner

Try Ageless

Best for: lowest-tier compounded GLP-1 in injection, troche and sublingual forms

★★★3.5/5

Editorial score · methodology

$119/mosemaglutide
$169/motirzepatide
CompoundedSemaglutideTirzepatideGonadorelinNAD+LegitScript Verified
Get StartedRead full Try Ageless review →
AMP Health logo
3.3 / 5
Our editorial rating

AMP Health at a glance

Type
GLP-1 telehealth provider
Medications
Semaglutide, Tirzepatide
Starting price
$199/mo (Plus $79/mo subscription)
FDA status
1 FDA warning letter on record — see below

How we scored AMP Health

Each dimension is scored algorithmically from AMP Health’s real pricing, drugs offered, verification status, and disclosed inclusions — using the same six-dimension framework we apply to every provider.

Value25%

6.4/10

At $199/mo, AMP Health runs about 17% above the $170 median for GLP-1 providers.

Effectiveness25%

8.0/10

AMP Health offers both semaglutide and tirzepatide — the two GLP-1 molecules with the strongest published weight-loss trial outcomes. An oral/needle-free option is offered for patients who avoid injections.

User Experience15%

6.7/10

Online intake and platform experience; 4 platform features disclosed.

Trust & Safety15%

5.5/10

Core details confirmed by our editors; an FDA warning letter is on file (see flag above); dispenses through an accredited compounding pharmacy.

Accessibility10%

5.9/10

AMP Health's exact state footprint isn't published — confirm coverage in your state before signing up.

Support10%

5.7/10

AMP Health provides standard clinician follow-up; no extended coaching or community program is disclosed.

6scored dimensions
607providers compared
100%verified against live provider sites
Value 25%Effectiveness 25%User Experience 15%Trust & Safety 15%Accessibility 10%Support 10%

Providers that don’t post pricing up front score lower on Value and carry a cost-transparency note in their review. Read the full methodology →

How we verified this AMP Health review

Last checked August 2026
  • Confirmed current pricing across 3 dose/plan tiers
  • Checked the FDA warning-letter database for enforcement actions
  • Walked the public intake/checkout flow on the provider's site

Pricing, availability, and compliance facts come from the provider's own site and primary regulatory records — see the sources below. Editorial confidence in this data: medium.

What to expect when you sign up with AMP Health

We walked AMP Health’s public signup flow in July 2026 to document the process — the steps, pricing transparency, and what’s required — before you commit. (We don’t create accounts, enter medical information, or check out; this is the observable funnel, not a prescribing outcome.)

  1. 1A board-certified, licensed healthcare provider reviews your health history via a telehealth call (audio or video).
  2. 2If appropriate, the provider prescribes a GLP-1 medication.
  3. 3Treatment starts at a low dose and increases after about 3-4 weeks.
  4. 4Progress is monitored monthly with dosage adjustments as needed.
Price shown before you start
  • GLP-1 weight-loss telehealth offering semaglutide and tirzepatide; medication cost is separate from the subscription.
  • Stated $79.00/month subscription that includes a personal nutrition plan, ongoing check-ins, and education.
  • Explicitly available only in New York and New Jersey.
  • No long-term contracts or cancellation fees per the FAQ.
  • At time of visit the homepage was displaying an 'under maintenance' page advertising a free first month of weight-loss medication.

GLP-1 medications AMP Health offers

Tap any medication to read our plain-English guide — how it works, dosing, side effects, and what the trials found.

Pricing

Prices re-verified

Compounded SemaglutideCompounded
$199/mo
semaglutide

Plus $79/mo subscription

Oral SemaglutideCompounded
$199/mo
semaglutide

Plus $79/mo subscription

Compounded TirzepatideCompounded
$309/mo
tirzepatide

Plus $79/mo subscription

Ready to get started?

Plans and promotions change often — check AMP Health's current pricing and active discounts before you decide.

What we like

  • Semaglutide in both injectable and oral formats
  • Tirzepatide available
  • 30-day satisfaction guarantee
  • Personal nutrition plan and health coaching included

Watch-outs

  • $79/mo subscription fee on top of medication ($278–$388/mo total)
  • No visible LegitScript or PCAB accreditation
  • No physical address disclosed
  • States served not disclosed
  • Brand Wegovy listed but out of stock

AMP Health, reviewed honestly: a thin offer wrapped around an open question

AMP Health pitches itself as a one-stop shop for compounded GLP-1 weight-loss medication, leading with the thing most patients want to hear about semaglutide: you can get it as a shot or as a daily oral version, and it comes bundled with a nutrition plan and health coaching. On paper that's a reasonable package. In practice, the most important fact about AMP Health right now is one the marketing won't tell you: at our last check the live site was sitting behind a maintenance page, and the parts that still worked funneled you toward a booking call rather than a real checkout. That single detail shapes everything below, so read the whole thing before you hand over a card.

What it actually sells, and how the money really works

AMP Health's lineup is straightforward: compounded semaglutide in both injectable and oral form, and compounded tirzepatide. It also lists brand-name Wegovy, but that's been showing as out of stock, so treat it as a placeholder rather than a real option. The pricing structure is where you need to slow down. The medication has a monthly cost, and then there's a separate recurring subscription fee stacked on top of it every month. That second charge is easy to miss when you're scanning a headline number, and it meaningfully raises what you actually pay. Because the site was down at our last verification, we are not posting a specific rate here — the figures the company last published are currently unconfirmable. The honest move is to get the all-in monthly total in writing, medication plus subscription, before you commit. For reference, the typical price across the providers we track sits around $170 a month for the medication itself, so use that as a sanity check when AMP quotes you.

  • Two charges, not one — the medication price and a monthly subscription fee are billed separately, so budget for the combined total.
  • Oral semaglutide is the genuine hook — if needles are your dealbreaker, a daily pill version is the main reason to look here.
  • Brand Wegovy is listed but out of stock — don't choose AMP expecting brand-name product.
  • A 30-day satisfaction guarantee is advertised — worth confirming the exact refund terms while the site is restored.

The medications and how they're dispensed

Everything weight-loss here is compounded, meaning it's mixed by a pharmacy rather than supplied as an FDA-approved branded product. Compounded semaglutide and tirzepatide are the same active ingredients found in the well-known brands, but the formulation, dosing, and quality controls depend entirely on the pharmacy behind them. And that's exactly where AMP Health goes quiet: the record we have lists no named compounding partner, no LegitScript certification, and no PCAB-accredited pharmacy. For a category where the pharmacy is the whole safety story, that's a notable blank. The oral option is the standout — a swallow-it daily formulation rather than a weekly injection — and that convenience is the clearest reason someone would pick AMP over a more transparent competitor.

The differentiator nobody advertises: the site was in maintenance mode

Here's the part that earns AMP Health its skepticism. When we went to verify its offer, the homepage was serving a maintenance page rather than a working store, promoting a 'first month free' teaser. The normal shopping route had been replaced: the product pages redirected into a phone-booking widget, the kind of call-funnel setup where a rep walks you toward signing up rather than a self-serve checkout you control. On top of that, the site's underlying code still referenced an old SlimMD logo — strong evidence that AMP Health is a rebrand of a previous operation rather than a brand-new company with the track record it implies. None of that is automatically disqualifying, but combined, it paints a picture of an offer in flux, with pricing and availability you cannot independently confirm today.

Who it's genuinely for — and who should walk

AMP Health makes the most sense for a narrow type of patient: someone set on oral semaglutide who also wants coaching and a nutrition plan folded in, and who is comfortable getting on a phone call to sort out the details. If that's you, go in with eyes open and pin down the pharmacy, the all-in price, and the refund window before paying.

You should skip it if you want transparency you can verify before you buy. There's no disclosed physical address, no published list of states served, no visible pharmacy accreditation, and — at last check — no functioning storefront. If you value brand-name product, a clear and accountable pharmacy, or simply the ability to see exactly what you're charged before committing, several providers we rank are far more upfront. The bundled subscription fee also makes AMP pricier than the bare medication number suggests, so a 'cheap' first impression can be misleading.

Trust and safety: the weakest part of the file

AMP has an FDA warning letter on record, covered in the regulatory notice below. To its credit, it advertises a satisfaction guarantee and coaching support. But trust is built on what a provider is willing to show you, and AMP shows very little: no accreditation, no address, no state disclosure, an out-of-stock brand listing, a maintenance-mode website, a booking-call funnel, and signs of a prior identity under a different name. That's a low-confidence profile. We'd want to see a named, accredited pharmacy and a working, transparent checkout before we'd rate the oversight here as reassuring. You can see how we weigh these signals in our scoring methodology.

Bottom line

AMP Health has a real selling point in oral semaglutide plus included coaching, but right now it's an offer you can't fully verify, sold through a booking call, behind a maintenance page, under what looks like a rebranded identity, with no visible pharmacy accreditation and a stacked subscription fee that inflates the true cost. If oral semaglutide is non-negotiable for you, it may be worth a cautious call — but get every number and the pharmacy name in writing first. For most people, a more transparent, accredited provider is the safer place to start.

Worth pricing against Eden ($198/month) and Breeze Meds ($199/month) before you commit — both sit close to AMP Health on cost and formulation.

The Bottom Line

AMP Health scores below our bar on medical oversight — read the score breakdown before signing up.

Score: 6.6/10Best for: patients wanting oral semaglutide with coaching supportFrom: $199/mo

AMP Health might not be your best fit if…

We rank editorially, so here’s where a different provider we track may serve you better.

  • If you want brand-name Ozempic, Wegovy, Mounjaro or Zepbound, consider GobyMeds.
  • If the lowest possible monthly price is your top priority, consider Collective (from $59/mo).
  • If you want built-in coaching and behavior-change support, consider Found.

Frequently Asked Questions

AMP Health is a telehealth provider offering compounded GLP-1 medications, including an oral semaglutide option, and it appears to be a rebrand of the earlier SlimMD service. A licensed clinician determines whether treatment is appropriate for you.
AMP Health offers compounded semaglutide in both injectable and oral forms and compounded tirzepatide; brand-name Wegovy has been listed but shown as out of stock. Compounded medications are not FDA-approved products.
Compounded semaglutide (injectable or oral) has been listed at $199/month and tirzepatide at $309/month, each with an additional $79/month subscription fee on top of the medication — roughly $278 to $388/month in total. Confirm current pricing directly, as it may change.
Yes, AMP Health lists semaglutide in an oral form as well as injectable. Which form, if any, is suitable is decided by a licensed clinician.
AMP Health advertises a 30-day satisfaction guarantee. Note that the site does not display LegitScript or PCAB accreditation and does not disclose a physical address or list of states served, so verify these details before enrolling.
At the last check, the AMP Health website was in maintenance mode and its e-commerce flow redirected to a phone-booking widget, so pricing and terms could not be re-verified. Confirm current availability, pricing, and terms directly with AMP Health before committing.
AMP Health is an operating telehealth provider, but it has an FDA warning letter on file — we flag it at the top of this review. Weigh that carefully and consult a licensed clinician before starting.
The biggest red flag is an FDA warning letter on file, which we flag at the top of this review — read it before starting. We also note: $79/mo subscription fee on top of medication ($278–$388/mo total); No visible LegitScript or PCAB accreditation; No physical address disclosed.

Key terms, explained

New to GLP-1s? Tap any term for a quick, plain-English definition.

Regulatory notice

AMP Health received an FDA warning letter dated February 20, 2026

The letter concerns false & misleading claims/misbranded. FDA warning letters are public regulatory communications and do not, on their own, constitute a finding of illegal activity — companies often respond with corrective action.

Read the full letter →

Sources

The primary regulatory filings and peer-reviewed studies cited throughout this AMP Health review:

Sources & methodology — as of September 2026
  1. 1.Weight Loss Rankings — GLP-1 Pricing Index 2026 (our independent dataset)WeightLossRankings.org.
  2. 2.FDA — Compounding and the 503A Pharmacy FrameworkU.S. Food & Drug Administration.
  3. 3.FDA — Drug Shortages Database (current shortage listings)U.S. Food & Drug Administration.
  4. 4.PCAB — Pharmacy Compounding Accreditation Board StandardsAccreditation Commission for Health Care (ACHC) / PCAB.
  5. 5.KFF — Medicaid coverage research (anti-obesity & GLP-1 drug policy)Kaiser Family Foundation.
  6. 6.STEP 1 Trial — Once-Weekly Semaglutide in Adults with Overweight or Obesity (Wilding JPH et al.)New England Journal of Medicine.PMID: 33567185.
  7. 7.FDA — Wegovy (semaglutide) Approval History via Drugs@FDAU.S. Food & Drug Administration.
  8. 8.FDA — Ozempic (semaglutide) Prescribing Information via Drugs@FDAU.S. Food & Drug Administration.
  9. 9.SURMOUNT-1 Trial — Tirzepatide Once Weekly for the Treatment of Obesity (Jastreboff AM et al.)New England Journal of Medicine.PMID: 35658024.
  10. 10.FDA — Zepbound (tirzepatide) Approval History via Drugs@FDAU.S. Food & Drug Administration.
  11. 11.FDA — Mounjaro (tirzepatide) Prescribing Information via Drugs@FDAU.S. Food & Drug Administration.
  12. 12.SURMOUNT-5 Trial — Tirzepatide vs. Semaglutide Head-to-Head in Obesity (Garvey WT et al.)New England Journal of Medicine.PMID: 40334173.